Global medical technology company BD (Becton, Dickinson and Company) has unveiled plans to build a A$260 million high-tech manufacturing facility in the city of Zaragoza, Spain.
The new 8,000 square meters facility will be the fourth manufacturing plant for BD in Spain and will produce drug delivery devices, primarily for pharmaceutical companies that supply the European market with drugs in pre-fillable syringes such as vaccines and other biologic drugs.
BD said it will also add needed capacity to support major vaccination campaigns, such as the one currently taking place in response to the COVID-19 pandemic.
According to the company’s statement, the new facility will meet high sustainability and eco-efficiency standards, and it will be a fully digital site, incorporating the latest in intelligent and autonomous technologies, also knowns as Industry 4.0 solutions.
BD plans to begin construction of the new plant in late 2021.
